Trials / Unknown
UnknownNCT03121729
Enhanced Recovery After Surgery Program for Gastric Cancer: a Multi-center Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,000 (estimated)
- Sponsor
- Jinling Hospital, China · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is aimed to evaluate the safety of applying enhanced recovery after surgery for gastric cancer.
Detailed description
In China, gastric cancer results in the second highest morbidity and mortality rates among all malignancies. It is very important for treatment of gastric cancer to enhance the quality of treatment, increase patients' survival rate and improve the life quality. Now, "Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology" and "Japanese gastric cancer treatment guidelines 2014 (ver. 4)" recommended surgical resection for gastric cancer. As a result, increasing the quality of surgery and improving the perioperative measures have a great influence on patients received a gastrectomy. Before, patients discharged on 7-10 days after gastrectomy and recovered 4-8 weeks after surgery. So, it is significant for patients to recover from surgical trauma in order to receive other anti-cancer therapies after gastrectomy. Investigators spent over ten years studying enhanced recovery after surgery programs for gastric cancer and have got some successful experience. Investigators found enhanced recovery after surgery can accelerate patients' recovery without increasing complications. This study is the first multi-center study of enhanced recovery after surgery for gastric cancer all over the world. During this period, the study is aimed to evaluate the safety of applying enhanced recovery after surgery for gastric cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | enhanced recovery after surgery | Undergo an enhanced recovery after surgery program |
Timeline
- Start date
- 2017-06-21
- Primary completion
- 2018-08-31
- Completion
- 2018-12-01
- First posted
- 2017-04-20
- Last updated
- 2018-04-30
Locations
23 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03121729. Inclusion in this directory is not an endorsement.